To further determine whether PrPC-Apt DOA inhibit the proliferation of CRC cells, western blot analysis was performed for cell cycle-associated proteins, such as cyclin-dependent kinase (CDK) 2, cyclin E, CDK4, and cyclin D1. The gene discussed is CCND1; the disease is colorectal carcinoma.